REVENUE INTEREST PURCHASE AGREEMENT dated as of September 12, 2022 among ADAPTIVE BIOTECHNOLOGIES CORPORATION, the Purchasers from time to time party hereto and ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP, as Purchaser AgentRevenue Interest Purchase Agreement • September 12th, 2022 • Adaptive Biotechnologies Corp • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 12th, 2022 Company Industry Jurisdiction